The article begins by discussing monitoring of treatment response and detection of extra-intestinal manifestations, followed by considerations in making treatment decisions before outlining novel therapy options in both UC and CD.
Medullary Carcinoma of the Pancreas: Report of a Rare Pancreatic Malignancy and Review of Literature
5 Mins
